Status:

COMPLETED

Pain and Quality of Life After Retromuscular Ventral Hernia Repair (RECOVER)

Lead Sponsor:

Intuitive Surgical

Conditions:

Ventral Hernia

Eligibility:

All Genders

18-89 years

Brief Summary

The study aims to explore the difference in outcomes relating to pain and quality of life after open, laparoscopic, and robotic-assisted retromuscular ventral hernia repair.

Detailed Description

This is a prospective, multicenter, observational study assessing outcomes relating to pain and quality of life for subjects undergoing open, laparoscopic, or robotic-assisted retromuscular ventral he...

Eligibility Criteria

Inclusion

  • Subject is between 18 and 89 years of age
  • Subject is a candidate for an elective retromuscular ventral hernia repair under general anesthesia
  • Subject has access to complete study assessments electronically and agrees to comply with all follow-up requirements
  • Ventral hernia is \>= 4cm

Exclusion

  • Subject who will have an emergent hernia repair
  • Subject has a parastomal hernia (i.e. hernia related to ostomy formation)
  • Subject with a history of chronic pain and/or taking daily pain medication for \>6 weeks
  • Subject wtih a history of substance abuse (excluding marijuana) and/or current (within 30 days) narcotic use
  • Subject with a history of MRSA infection
  • Subject with HbA1c level \> 8.5%
  • Subject undergoing a minimally invasive (MIS) repair who will require the use of Exparel during the surgical procedure
  • Subject who will undergo a concomitant hernia repair or any other concomitant procedure
  • Subject has cirrhosis
  • Current nicotine use (including vaping) within the past 30 days
  • Subject is contraindicated for general anesthesia or surgery
  • Subject has a known bleeding or clotting disorder
  • Pregnant or suspected pregnancy
  • Subject is mentally handicapped or has a psychological disorder or severe systemic illness that would preclude compliance with the study requirements or ability to provide informed consent
  • Subject belonging to other vulnerable population, e.g., prisoner or ward of state
  • Subject is currently participating in another interventional research study

Key Trial Info

Start Date :

July 16 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 19 2024

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT04487522

Start Date

July 16 2020

End Date

September 19 2024

Last Update

November 26 2024

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Kaiser Foundation Research Institute, Oakland/Richmond

Oakland, California, United States, 94612

2

Kaiser Foundation Research Institute, South Sacramento

Sacramento, California, United States, 95825

3

Kaiser Foundation Research Institute, Santa Clara

Santa Clara, California, United States, 95051

4

Kaiser Foundation Research Institute, Walnut Creek

Walnut Creek, California, United States, 94596